Used in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor ligands. It serves as a structural analog in developing compounds targeting neurological disorders such as Alzheimer's disease, schizophrenia, and nicotine addiction. Its derivatives are explored for their cognitive-enhancing and neuroprotective properties. Also employed in the development of PET imaging agents for studying receptor distribution in the brain.